Panx1 probably acts as a liver tumor promotor, since liver samples of patients with more advanced HCC express higher levels of Panx1 compared to liver samples of patients with less advanced HCC stages (Shi et al., 2019[55]). This evidence concerns the gene PANX1 and hepatocellular carcinoma.